MUNICH, Germany—In patients with stable coronary artery disease (CAD) and at least 1 proven ischemic stenosis, percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) plus ...

The totality of data suggests that routine PCI prior to TAVI is not warranted in the majority of cases, a meta-analysis shows ...

Forbes contributors publish independent expert analyses and insights. I'm a medical journalist covering cardiology news. Aug 28, 2012, 02:01am EDT Aug 28, 2012, 05:54am EDT This article is more than ...

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the U.S. clearance and launch of the company’s new PressureWire™ X Guidewire ...

When dual antiplatelet therapy was stopped 12 months after PCI, clopidogrel monotherapy lowered cardiovascular and bleeding ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — In the first randomized clinical trial to compare optimal medical therapy alone with PCI in ...

Please provide your email address to receive an email when new articles are posted on . For patients with vulnerable plaque but no flow-limiting stenosis, PCI provided better clinical outcomes than ...

DENVER, CO — PCI guided by fractional flow reserve (FFR) measurement plus medical therapy improved long-term outcomes for a majority of patients with stable coronary artery disease compared with ...

There is an imbalance between the rapid growth of cardiac catheterization laboratories, which provide percutaneous coronary intervention (PCI) procedures, relative to the growth in the overall U.S.

Patients with stable coronary artery disease (CAD) today do no better with stents than with medical therapy, according to a new meta-analysis published in the Archives of Internal Medicine. Kathleen ...